虚拟现实在重症监护病房中使用的范围审查

分享智慧

共同成长

Abstract

 Background

A wide range of reviews have demonstrated the effectiveness and tolerability of Virtual Reality (VR) in a range of clinical areas and subpopulations. However, no previous review has explored the current maturity, acceptability, tolerability, and effectiveness of VR with intensive care patients.

Aims

To identify the range of uses of VR for intensive care patients, classify their current phase of development, effectiveness, acceptability, and tolerability.

Methods

A scoping review was conducted. A multi-database search was undertaken (inception to January 2021). Any type of study which examined the use of VR with the target application population of intensive care patients were included. Screening, data extraction, and assessment of quality were undertaken by a single reviewer. A meta-analysis and a descriptive synthesis were undertaken.

Results

Six hundred and forty-seven records were identified, after duplicate removal and screening 21 studies were included (weak quality). The majority of studies for relaxation, delirium, and Post Traumatic Stress Disorder (PTSD) were at the early stages of assessing acceptability, tolerability, and initial clinical efficacy. Virtual Reality for relaxation and delirium were well-tolerated with completion rates of target treatment of 73.6%, (95% CI:51.1%-96%, I2 = 98.52%) 52.7% (95% CI:52.7%-100%, I2 = 96.8%). The majority of reasons for non-completion were due to external clinical factors. There were some potential benefits demonstrated for the use of VR for relaxation, delirium, and sleep.

Conclusion

Virtual Reality for intensive care is a new domain of research with the majority of areas of application being in the early stages of development. There is great potential for the use of VR in this clinical environment. Further robust assessment of effectiveness is required before any clinical recommendations can be made.

摘要翻译（仅供参考）

背景介绍

大量的评论已经证明了虚拟现实（VR）在一系列临床领域和亚人群中的有效性和耐受性。然而，以前没有任何评论探讨了VR在重症监护患者中的当前成熟度、可接受性、可容忍性和有效性。

目的

确定重症监护患者使用VR的范围，对其目前的发展阶段、有效性、可接受性和可耐受性进行分类。

方法

进行了一个范围审查。进行了多数据库检索（从开始到2021年1月）。包括任何类型的研究，研究VR在重症监护患者目标应用人群中的使用。筛选、数据提取和质量评估由一名评审员进行。进行了荟萃分析和描述性综合。

结果

确定了六百四十七条记录，在去除重复和筛选后，纳入了21项研究（质量较差）。大多数关于放松、谵妄和创伤后应激障碍（PTSD）的研究处于评估接受性、耐受性和初步临床疗效的早期阶段。用于放松和谵妄的虚拟现实技术耐受性良好，目标治疗的完成率为73.6%，（95% CI:51.1%-96%，I2 = 98.52%）52.7%（95% CI:52.7%-100%，I2 = 96.8%）。大多数未完成的原因是由于外部临床因素。在放松、谵妄和睡眠方面，使用VR有一些潜在的好处。

结论

用于重症监护的虚拟现实技术是一个新的研究领域，大部分的应用还处于早期发展阶段。在这个临床环境中使用VR有很大的潜力。在提出任何临床建议之前，需要对有效性进行进一步的有力评估。

原文链接：

https://doi.org/10.1111/nicc.12732

THE

END